ITMCTR2000004058招募中1 期
Study on Bone Metabolic Mechanism and Clinical Application of Qianggu Yin in the treatment of Primary Type I Osteoporosis
The Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 55 至 65（—）
- 性别
- Female
入选标准
- •According to the diagnostic criteria of osteoporosis; postmenopausal women; 55-65 years old.
排除标准
- •1.Diabetes mellitus, Cushing syndrome, changes in thyroid or parathyroid function, osteomalacia, rheumatoid arthritis, multiple myeloma, bone tumor, osteoarthropathy, Paget's disease, osteogenesis imperfecta and other diseases that seriously affect bone or calcium metabolism;
- •2.has taken estrogen, steroid hormone, calcitonin, parathyroid hormone, and both in the past 6 months Phosphate, fluoride, vitamin D, anticonvulsants, diuretics and other drugs that affect bone metabolism;
- •3.combined with cardiovascular, cerebrovascular, hematopoietic system and other serious primary type I disease; combined with severe liver and kidney dysfunction; mental illness or Alzheimer's disease.
研究者
相似试验
招募中
不适用
Evaluation of metabolic bone disease and fracture prevalence in patients with Crohn’s diseaseK50.9M82Crohn disease, unspecifiedOsteoporosis in diseases classified elsewhereDRKS00013028udwig Boltzmann Institut für Osteologie218
招募中
不适用
Metabolic Profile of Bone in Professional AthletesBone Disease, MetabolicPhysical ActivityNCT03386981I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio200
已完成
不适用
Inflammatory markers in orthodontic treatment with clear aligners: split mouth clinical trialMalocclusionISRCTN32624758niversity of Torino21
招募中
不适用
The evaluations of glucose metabolism, bone metabolism, vascular endothelial function and lipid metabolism by the hormone which regulates circadian rhythm in type 2 diabetes.JPRN-UMIN000019018niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine168
已完成
不适用
Study on the effect on bone metabolism markers of ARB combination drug that targets high blood pressure patientsHypertensionJPRN-UMIN000014135Saitama Medical University30